$ATEX

Kuhn Thomas R. sold $1.0M of ATEX

Kuhn Thomas R. sold 11,654 shares of Anterix Inc. (ATEX) at an average of $87.53 ($79.52–$91.01, $1.02M total) across 5 trades over 2026-06-18 to 2026-08-24.

Original reporting
SEC EDGAR · Kuhn Thomas R.
Published Aug 26, 2026, 8:46 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATEX
Bearish
medium confidence
Mentioned
$ATEX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings, offering a modest trading cue for ATEX.

02

Market read

Primary insider sale filing; modest relevance for short‑term traders of ATEX.

03

What to watch

Potential upcoming financing needs or personal tax planning could explain the sale without implying company weakness.

Relevance 6/10Novelty 5/10Timing: filed 2026‑08‑26

Background

Form 4 filings disclose insider transactions; investors monitor them for signals about management confidence.

Company-level read

Ticker impact

$ATEXBearishMedium confidence
Context

Director Thomas R. Kuhn sold ~1 M USD of ATEX shares via open‑market trades, reducing his holding to 17,731 shares.

Expected impact

Modest downside pressure; possible 2‑3% dip over the next few days.

Evidence & confidence

A $1 M sale by a director is material for a micro‑cap like ATEX, but the amount is modest relative to market cap, so impact is limited.

Market effects

Minimal; insider activity unlikely to affect the broader telecom equipment sector.

None; ATEX trades primarily on US exchanges.

Low; the filing is company‑specific.

Counterpoint

The sale could be a routine liquidity move, not a negative signal; price may remain stable.

Key entities

  • Anterix Inc.

    Issuer of the ATEX ticker, a provider of wireless network solutions.

  • Thomas R. Kuhn

    Director of Anterix who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2